Cord blood is a valuable source of hematopoietic stem cells that have been widely used in the treatment of blood disorders, including leukemia and lymphoma. It also holds significant promise in regenerative medicine, supporting tissue repair and future therapeutic applications. Autologous cord blood stem cells offer excellent immune compatibility, helping to reduce the risk of transplant rejection.

Preserving cord blood at birth provides a valuable biological resource for potential future medical use. Our advanced processing technology isolates and concentrates stem cells to maximize cell purity and viability while minimizing cell loss during long-term storage.

Key Features Include:

• Multi-segment storage to reduce contamination risks and support future use. Precision cryogenic preservation to maintain optimal cell activity

• Real-time monitoring and traceability for enhanced sample security. Automated management and continuous temperature control to ensure consistent quality

With stringent storage standards and quality control, we preserve the long-term viability of cord blood stem cells for future medical and regenerative applications.

From development through production, our cord blood products are managed under rigorous quality standards. Comprehensive validation and qualification processes help ensure exceptional quality, safety, and long-term preservation performance.
Our quality assurance program includes rigorous testing of cell viability, cell count, sterility, cryopreservation efficiency, biocompatibility, and seal integrity. All procedures are performed in compliance with established industry regulations and quality standards.

To further ensure safety and reliability, our preservation systems are regularly tested and verified by independent third-party laboratories. These consistent results reflect our commitment to delivering safe, stable, and premium-quality cord blood preservation services

To ensure the absolute safety, efficacy, and clinical readiness of every cord blood unit, we perform rigorous screening across five critical benchmarks:

• Total Nucleated Cell Count (TNC): Measures the overall quantity of nucleated cells within the cord blood to ensure an adequate cell dose for clinical use.

• Stem Cell Viability: Evaluates the health and survival rate of the stem cells, guaranteeing their potency and effectiveness during future treatments.

• CD34+ Stem Cell Count: Quantifies the exact number of hematopoietic stem cells to confirm the unit meets stringent clinical transplant requirements.

• Microbial Testing: Screens the sample to guarantee the final cord blood product is entirely free from bacterial or fungal contamination, ensuring patient safety.

• Maternal Virus Testing: Screens the maternal blood for pathogenic viruses—including HIV, HBV, HCV, and HTLV—to prevent the risk of infectious disease transmission. Every test is performed in strict compliance with international standards, delivering a safe, premium, and transplant-ready product for clinical application.

The laboratory performs routine Colony-Forming Unit (CFU) testing using reference samples to validate the preservation performance of our storage tanks, ensuring the long-term viability and efficacy of every client's stored specimen.

Our laboratory operates under a fully integrated quality and risk management framework designed to ensure continuous safety, reliability, and regulatory compliance. This system provides comprehensive oversight across all operational stages, supporting data integrity, system stability, and continuous process improvement. Key systems and safeguards include:

• End-to-End Surveillance Continuous tracking across cell release, transportation, and transplantation to ensure full compliance with global quality standards.

• Software & Data Security Regular system updates and reinforced backup protocols to ensure uninterrupted data integrity and cybersecurity protection.

• Emergency Contingency Systems Real-time alerts and automated backup power systems to protect stored products in the event of power outages or equipment anomalies.

• Rigorous CAPA Program Immediate root-cause analysis for any Non-Conformance Report (NCR), ensuring timely corrective and preventive actions and continuous operational improvement.